{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
NCT00196417: Phase 4 Interventional Unknown status Heparin-Induced Thrombocytopenia
(2003)
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Class:
POLYMER
Status:
US Approved Rx
(2015)
First approved in 2015
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2015)
First approved in 2015
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2015)
First approved in 2009
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2015)
First approved in 2009
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2016)
First approved in 2007
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2007)
First approved in 2007
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2014)
First approved in 1998
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2012)
First approved in 1998
Class:
STRUCTURALLY DIVERSE